ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $123,000 | -24.1% | 42,700 | 0.0% | 0.00% | – |
Q4 2019 | $162,000 | -25.7% | 42,700 | 0.0% | 0.00% | – |
Q3 2019 | $218,000 | -29.2% | 42,700 | -14.1% | 0.00% | – |
Q2 2019 | $308,000 | -9.7% | 49,700 | +3.5% | 0.00% | – |
Q1 2019 | $341,000 | -96.7% | 48,000 | -96.1% | 0.00% | -100.0% |
Q4 2018 | $10,469,000 | -38.2% | 1,225,839 | +44.8% | 0.01% | -27.3% |
Q3 2018 | $16,945,000 | -8.5% | 846,379 | +18.1% | 0.01% | -15.4% |
Q2 2018 | $18,510,000 | +17.9% | 716,616 | +9.1% | 0.01% | +18.2% |
Q1 2018 | $15,705,000 | -29.5% | 657,106 | -0.1% | 0.01% | -31.2% |
Q4 2017 | $22,291,000 | +81.4% | 657,737 | +13.3% | 0.02% | +77.8% |
Q3 2017 | $12,288,000 | -2.1% | 580,434 | -19.1% | 0.01% | -10.0% |
Q2 2017 | $12,551,000 | +2.5% | 717,617 | +2.6% | 0.01% | 0.0% |
Q1 2017 | $12,244,000 | -1.5% | 699,645 | -4.9% | 0.01% | 0.0% |
Q4 2016 | $12,428,000 | +8.4% | 735,394 | +5.3% | 0.01% | 0.0% |
Q3 2016 | $11,463,000 | +16.2% | 698,508 | +7.2% | 0.01% | +25.0% |
Q2 2016 | $9,866,000 | +3.4% | 651,667 | -1.2% | 0.01% | 0.0% |
Q1 2016 | $9,540,000 | +3809.8% | 659,760 | +7571.6% | 0.01% | – |
Q4 2015 | $244,000 | +275.4% | 8,600 | +132.4% | 0.00% | – |
Q1 2015 | $65,000 | +828.6% | 3,700 | +825.0% | 0.00% | – |
Q4 2014 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q3 2014 | $7,000 | -53.3% | 400 | -50.0% | 0.00% | – |
Q2 2014 | $15,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCP Investment, LP | 288,185 | $5,769,000 | 4.67% |
Broadfin Capital, LLC | 1,328,424 | $26,595,000 | 3.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 370,000 | $5,672,000 | 2.70% |
Brenner West Capital Advisors | 1,011,431 | $20,249,000 | 2.52% |
Opus Point Partners Management, LLC | 44,500 | $891,000 | 2.13% |
SECTORAL ASSET MANAGEMENT INC | 903,424 | $18,087,000 | 1.92% |
DELTEC ASSET MANAGEMENT LLC | 379,424 | $7,596,000 | 1.46% |
Kerrisdale Advisers, LLC | 72,840 | $1,458,000 | 1.43% |
ARDSLEY ADVISORY PARTNERS LP | 510,000 | $10,210,000 | 1.38% |
MORGENS WATERFALL VINTIADIS & CO INC | 50,000 | $1,001,000 | 0.66% |